tiprankstipranks
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market
ORKA
Oruka Therapeutics
RESEARCH TOOLSreports

Oruka Therapeutics (ORKA) Financial Statements

Compare
757 Followers

Oruka Therapeutics Financial Overview

Oruka Therapeutics's market cap is currently $2.25B. The company's EPS TTM is $-0.45; its P/E ratio is -13.11; Oruka Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -83.00K$ -27.00K$ -114.00K$ -91.00K$ -93.00K
Operating Income$ -122.05M$ -88.12M$ -9.84M$ -19.34M$ -9.77M
EBITDA$ -121.97M$ -82.23M$ -9.81M$ -19.23M$ -9.64M
Net Income$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.74M
Balance Sheet
Cash & Short-Term Investments$ 337.04M$ 375.65M$ 42.45M$ 53.36M$ 49.07M
Total Assets$ 488.62M$ 396.02M$ 43.09M$ 54.92M$ 50.43M
Total Debt$ 1.93M$ 968.00K$ 383.00K$ 483.00K$ 450.00K
Net Debt$ -45.00M$ -60.61M$ -42.06M$ -52.88M$ -48.62M
Total Liabilities$ 16.69M$ 13.80M$ 1.41M$ 3.88M$ 3.91M
Stockholders' Equity$ 471.93M$ 382.22M$ 41.67M$ 51.04M$ 46.52M
Cash Flow
Free Cash Flow$ -88.42M$ -58.03M$ -10.91M$ -18.80M$ -7.74M
Operating Cash Flow$ -88.21M$ -57.84M$ -10.91M$ -18.76M$ -7.72M
Investing Cash Flow$ -96.75M$ -330.13M$ -2.00K$ -43.00K$ -19.00K
Financing Cash Flow$ 170.31M$ 449.54M$ 0.00$ 23.09M$ 48.45M
Currency in USD

Oruka Therapeutics Earnings and Revenue History

Income Statement >

Oruka Therapeutics Debt to Assets

Balance Sheet >

Oruka Therapeutics Cash Flow

Cash Flow >

Oruka Therapeutics Forecast EPS vs Actual EPS

Earnings >